| Table 3. The deployment of the ovarian stimulation protocol and doses of follicle-stimulating hormone (FSH) in the groups categorised by the ovarian response prediction index (ORPI) | |||
| ORPI values |
Oocyte number (expected) |
Protocol | Dose of FSH |
| preg<0.2 | ≤3 |
-GnRH Antagonist -Short GnRH Agonist -Clomiphene citrate + FSH -Long GnRH Agonist |
300 IU-150 IU |
| ≥0.2-<0.5 | 4-5 |
-GnRH Antagonist -Short GnRH Agonist -Long GnRH Agonist |
300 IU-150 IU |
| ≥0.5-<0.9 | 6-14 |
-Long GnRH Agonist -GnRH Antagonist |
150 IU-112.5 IU |
| ≥0.9 | ≥15 | -GnRH Antagonist | 112.5 IU-75 IU |